approval
saveYUVIWEL (NAVEPEGRITIDE) — FDA approval
community read0 votes
Sponsor: ASCENDIS. Form: POWDER. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 5mo ago
Found something off?
same company · ±60 days · 4
- approvalLISDEXAMFETAMINE DIMESYLATE: LISDEXAMFETAMINE DIMESYLATE — FDA approvalMar 18, 2026
- approvalGUANFACINE HYDROCHLORIDE: GUANFACINE HYDROCHLORIDE — FDA approvalMar 24, 2026
- approvalBUPRENORPHINE HYDROCHLORIDE: BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE (BUPRENORPHINE HYDROCHLORIDE) — FDA approvalJan 21, 2026
- approvaltopiramate ER: TOPIRAMATE — FDA approvalJan 12, 2026
comments(0)
5-min edit window · permanent after that